These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16421797)

  • 21. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
    Cebríán L; Rodríguez JC; Escribiano I; Royo SG
    APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
    Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
    Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of probability of target attainment calculated by Monte Carlo simulation with meropenem clinical and microbiological response for the treatment of complicated skin and skin structure infections.
    Kuti JL; Ong C; Lo M; Melnick D; Soto N; Nicolau DP
    Int J Antimicrob Agents; 2006 Jul; 28(1):62-8. PubMed ID: 16759839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity of selected plant species from "the Argentine Puna" against sensitive and multi-resistant bacteria.
    Zampini IC; Cuello S; Alberto MR; Ordoñez RM; D' Almeida R; Solorzano E; Isla MI
    J Ethnopharmacol; 2009 Jul; 124(3):499-505. PubMed ID: 19467313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: a pharmacodynamic in vitro model approach to selection of resistant populations.
    Sevillano D; Aguilar L; Alou L; Giménez MJ; Echevarría O; Cafini F; Valero E; Fenoll A; Prieto J
    J Antimicrob Chemother; 2006 Oct; 58(4):794-801. PubMed ID: 16880173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of resistance in microorganisms by help of non-antibiotics.
    Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H
    J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.
    Dutta NK; Annadurai S; Mazumdar K; Dastidar SG; Kristiansen JE; Molnar J; Martins M; Amaral L
    Int J Antimicrob Agents; 2007 Sep; 30(3):242-9. PubMed ID: 17644318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Voice on the treatment of ureaplasmas infections].
    Biernat-Sudolska M; Rojek-Zakrzewska D; Drzewiecki A
    Przegl Epidemiol; 2009; 63(1):85-8. PubMed ID: 19522233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The issue of antimicrobial resistance in human medicine.
    Beović B
    Int J Food Microbiol; 2006 Dec; 112(3):280-7. PubMed ID: 16815582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic resistance of bacterial strains in paediatric infections: there are resistance and resistance!].
    Bingen E
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S49-52. PubMed ID: 19000854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection.
    Bradley JS; Garonzik SM; Forrest A; Bhavnani SM
    Pediatr Infect Dis J; 2010 Nov; 29(11):1043-6. PubMed ID: 20975453
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
    Tillotson GS; Draghi DC; Sahm DF; Tomfohrde KM; Del Fabro T; Critchley IA
    J Antimicrob Chemother; 2008 Jul; 62(1):109-15. PubMed ID: 18397923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-related selection of fluoroquinolone-resistant Escherichia coli.
    Olofsson SK; Marcusson LL; Strömbäck A; Hughes D; Cars O
    J Antimicrob Chemother; 2007 Oct; 60(4):795-801. PubMed ID: 17635875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
    Watanabe S; Ito T; Hiramatsu K
    J Antimicrob Chemother; 2007 Dec; 60(6):1384-7. PubMed ID: 17890283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.